Louise Ingram

Louise Ingram is a seasoned professional in process development and manufacturing sciences with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director at Fresenius Kabi since September 2017, previous roles include Director of Downstream Process Development and Head of Downstream Development for Biosimilars. Prior to this, Louise held the position of Head of Downstream Development for Biosimilars at Merck Serono and spent over 13 years at Lonza in various leadership roles, including Senior Group Leader, where responsibilities included managing virus reduction studies for monoclonal antibodies and recombinant proteins. Louise Ingram holds a BSc (Hons) in Biomedical Sciences from the University of the West of England and A levels in Biology, Chemistry, Psychology, and Environmental Science from Lewes Tertiary College.